scholarly journals The CONSORT statement and its impact on quality of reporting of trials

2019 ◽  
Vol 10 (4) ◽  
pp. 145
Author(s):  
Priya Ranganathan
Keyword(s):  
Consort Statement ◽  
Quality Of Reporting ◽  
The Consort Statement

scholarly journals Revised Standards for Reporting Interventions in Clinical Trials of Acupuncture (Stricta): Extending the Consort Statement

2010 ◽  
Vol 28 (2) ◽  
pp. 83-93 ◽  
Author(s):  
Hugh MacPherson ◽  
Douglas G Altman ◽  
Richard Hammerschlag ◽  
Youping Li ◽  
Taixiang Wu ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Expert Panel ◽  
Case Reports ◽  
Consort Statement ◽  
Quality Of Reporting ◽  
Revision Process ◽  
Face To Face ◽  
Journal Editors ◽  
The Consort Statement

The STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) were published in five journals in 2001 and 2002. These guidelines, in the form of a checklist and explanations for use by authors and journal editors, were designed to improve reporting of acupuncture trials, particularly the interventions, thereby facilitating their interpretation and replication. Subsequent reviews of the application and impact of STRICTA have highlighted the value of STRICTA as well as scope for improvements and revision. To manage the revision process a collaboration between the STRICTA Group, the CONSORT Group and the Chinese Cochrane Centre was developed in 2008. An expert panel with 47 participants was convened that provided electronic feedback on a revised draft of the checklist. At a subsequent face-to-face meeting in Freiburg, a group of 21 participants further revised the STRICTA checklist and planned dissemination. The new STRICTA checklist, which is an official extension of CONSORT, includes 6 items and 17 subitems. These set out reporting guidelines for the acupuncture rationale, the details of needling, the treatment regimen, other components of treatment, the practitioner background and the control or comparator interventions. In addition, and as part of this revision process, the explanations for each item have been elaborated, and examples of good reporting for each item are provided. In addition, the word ‘controlled’ in STRICTA is replaced by ‘clinical’, to indicate that STRICTA is applicable to a broad range of clinical evaluation designs, including uncontrolled outcome studies and case reports. It is intended that the revised STRICTA checklist, in conjunction with both the main CONSORT statement and extension for non-pharmacological treatment, will raise the quality of reporting of clinical trials of acupuncture.

scholarly journals Protocol of investigation into reporting quality of RCT abstracts on COVID-19 pursuant to CONSORT (CoCo study)—a review

Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Sabrina Tulka ◽  
Christine Baulig ◽  
Stephanie Knippschild
Keyword(s):  
Reporting Quality ◽  
Consort Statement ◽  
Cochrane Library ◽  
Current Crisis ◽  
Quality Of Reporting ◽  
Essential Information ◽  
Emergency Situations ◽  
Research Activities ◽  
The Consort Statement

Abstract Background In 2020, the COVID-19 pandemic developed into a global crisis, the enormity and urgency of which accelerated research activities in the field. At the same time, manuscripts describing these research projects underwent fast-track peer review procedures and were published in freely accessible formats. Although full texts about COVID-19 are currently available for free, abstracts continue to play a key role since they provide essential information and possibly a decision basis for therapies. Abstracts are particularly important in case the full texts are not free, not all reports have been published in English and in emergency situations when there is less time for comprehensive analysis of all full texts. It is therefore necessary to ensure that abstracts—as publications in miniature format—contain comprehensive and transparent information. The CONSORT statement for abstracts (CONSORT-A) offers guidelines to authors how to include all necessary information in an abstract. Prior to the COVID-19 pandemic, the quality of reporting in medical research had already been the object of debate and criticism. The current crisis makes comprehensive documentation all the more important. Abstracts of COVID-19 RCTs should therefore report the criteria listed in the CONSORT-A statement fully and verifiably. The objective of this study is to check the completeness of abstracts of all COVID-19 RTCs published to date. Methods Based on a literature search in PubMed, Embase and the Cochrane Library, all publications up to 29 October 2020 are identified and examined in terms of the subject matter (reported results from COVID-19 studies) and their study design (RTC). Subsequently, suitable publications are examined for completeness and quality of abstracts. The CONSORT checklist for RTC abstracts serves as a basis in this procedure. The primary endpoint of the study is the percentage of correctly implemented items of the CONSORT statement for abstracts. The frequency of correct reporting of each individual item is checked in a second step. Discussion The study is expected to contribute to evaluating the reporting quality on COVID-19 studies, and specifically the completeness of abstracts of RTCs. It may thus support the assessment of current research into COVID-19. Trial registration Registration was not required as the study investigated existing literature.

scholarly journals Using the CONSORT statement to evaluate the completeness of reporting of addiction randomised trials: a cross-sectional review

BMJ Open ◽  
2019 ◽  
Vol 9 (9) ◽  
pp. e032024 ◽  
Author(s):  
Matthew Vassar ◽  
Sam Jellison ◽  
Hannah Wendelbo ◽  
Cole Wayant ◽  
Harrison Gray ◽  
...  
Keyword(s):  
Reporting Quality ◽  
Consort Statement ◽  
Quality Of Reporting ◽  
Cross Sectional ◽  
The Consort Statement ◽  
Pubmed Search ◽  
Randomised Controlled ◽  
Poor Reporting ◽  
Completeness Of Reporting

ObjectivesEvaluate the completeness of reporting of addiction randomised controlled trials (RCTs) using the Consolidated Standards of Reporting Trials (CONSORT) statement.SettingNot applicable.ParticipantsRCTs identified using a PubMed search of 15 addiction journals and a 5-year cross-section.Outcome measuresCompleteness of reporting.ResultsOur analysis of 394 addiction RCTs found that the mean number of CONSORT items reported was 19.2 (SD 5.2), out of a possible 31. Twelve items were reported in <50% of RCTs; similarly, 12 items were reported in >75% of RCTs. Journal endorsement of CONSORT was found to improve the number of CONSORT items reported.ConclusionsPoor reporting quality may prohibit readers from critically appraising the methodological quality of addiction trials. We recommend journal endorsement of CONSORT since our study and those previous have shown that CONSORT endorsement improves the quality of reporting.

Sign in / Sign up

Export Citation Format

Share Document